SCHEMBL21180013

SCHEMBL21180013

CC(C)(C)OC(=O)C1C[C@H]([SH](=O)=O)C(c2ccccc2Cl)N1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.36
FFAR2 O15552 7/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ALOX15 P16050 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
FABP5 Q01469 1/20 0.32
BTK Q06187 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19428590 0.81 FABP5 (0.41) PDE5AL3MBTL1ALDH1A1KDM4EGLA
SCHEMBL14649976 0.81 FABP5 (0.41) PDE5AL3MBTL1ALDH1A1KDM4EGLA
SCHEMBL14653133 0.78 KDM4E (0.33) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E
SCHEMBL12643732 0.78 KDM4E (0.33) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E
SCHEMBL2039074 0.73 ALDH1A1 (0.43) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E
SCHEMBL2039076 0.73 ALDH1A1 (0.43) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E
SCHEMBL29788206 0.73 ALDH1A1 (0.43) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E
SCHEMBL29788153 0.68 HSD17B10 (0.41) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E
SCHEMBL2040425 0.68 HSD17B10 (0.41) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E
SCHEMBL2040422 0.68 HSD17B10 (0.41) PDE5AFFAR2L3MBTL1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10358416-B2 Substituted pyrrolidines as G-protein coupled receptor 43 agonists EPICS THERAPEUTICS (BE) 2019-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10358416-B2 Substituted pyrrolidines as G-protein coupled receptor 43 agonists GIPR, GPR88, GPR119 PDE5A 820/4885FFAR2 20/4885L3MBTL1 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.